These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 11790777

  • 1. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
    Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, Goldberg IJ.
    J Biol Chem; 2002 Mar 22; 277(12):10037-43. PubMed ID: 11790777
    [Abstract] [Full Text] [Related]

  • 2. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH, Bisgaier CL, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL.
    J Clin Invest; 1995 Dec 22; 96(6):2555-68. PubMed ID: 8675619
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
    Shimada M, Shimano H, Gotoda T, Yamamoto K, Kawamura M, Inaba T, Yazaki Y, Yamada N.
    J Biol Chem; 1993 Aug 25; 268(24):17924-9. PubMed ID: 8349676
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
    van der Hoogt CC, Berbée JF, Espirito Santo SM, Gerritsen G, Krom YD, van der Zee A, Havekes LM, van Dijk KW, Rensen PC.
    Biochim Biophys Acta; 2006 Feb 25; 1761(2):213-20. PubMed ID: 16478678
    [Abstract] [Full Text] [Related]

  • 5. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis.
    Goudriaan JR, Espirito Santo SM, Voshol PJ, Teusink B, van Dijk KW, van Vlijmen BJ, Romijn JA, Havekes LM, Rensen PC.
    J Lipid Res; 2004 Aug 25; 45(8):1475-81. PubMed ID: 15145981
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis.
    Boisfer E, Lambert G, Atger V, Tran NQ, Pastier D, Benetollo C, Trottier JF, Beaucamps I, Antonucci M, Laplaud M, Griglio S, Chambaz J, Kalopissis AD.
    J Biol Chem; 1999 Apr 23; 274(17):11564-72. PubMed ID: 10206963
    [Abstract] [Full Text] [Related]

  • 7. Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma.
    Levak-Frank S, Weinstock PH, Hayek T, Verdery R, Hofmann W, Ramakrishnan R, Sattler W, Breslow JL, Zechner R.
    J Biol Chem; 1997 Jul 04; 272(27):17182-90. PubMed ID: 9202040
    [Abstract] [Full Text] [Related]

  • 8. Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy.
    Vergès B, Vantyghem MC, Reznik Y, Duvillard L, Rouland A, Capel E, Vigouroux C.
    Arterioscler Thromb Vasc Biol; 2024 Aug 04; 44(8):1873-1883. PubMed ID: 38899472
    [Abstract] [Full Text] [Related]

  • 9. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.
    Salinelli S, Lo JY, Mims MP, Zsigmond E, Smith LC, Chan L.
    J Biol Chem; 1996 Sep 06; 271(36):21906-13. PubMed ID: 8702993
    [Abstract] [Full Text] [Related]

  • 10. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [Abstract] [Full Text] [Related]

  • 11. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice.
    Tacken PJ, Teusink B, Jong MC, Harats D, Havekes LM, van Dijk KW, Hofker MH.
    J Lipid Res; 2000 Dec 01; 41(12):2055-62. PubMed ID: 11108739
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
    Medh JD, Bowen SL, Fry GL, Ruben S, Andracki M, Inoue I, Lalouel JM, Strickland DK, Chappell DA.
    J Biol Chem; 1996 Jul 19; 271(29):17073-80. PubMed ID: 8663292
    [Abstract] [Full Text] [Related]

  • 13. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
    Liang K, Oveisi F, Vaziri ND.
    Kidney Int; 1998 Mar 19; 53(3):626-30. PubMed ID: 9507207
    [Abstract] [Full Text] [Related]

  • 14. The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI.
    Hu L, van der Hoogt CC, Espirito Santo SM, Out R, Kypreos KE, van Vlijmen BJ, Van Berkel TJ, Romijn JA, Havekes LM, van Dijk KW, Rensen PC.
    J Lipid Res; 2008 Jul 19; 49(7):1553-61. PubMed ID: 18367731
    [Abstract] [Full Text] [Related]

  • 15. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ, Beer FD, Vark LC, Havekes LM, Hofker MH, Willems Van Dijk K.
    Biochem J; 2000 Apr 15; 347(Pt 2):357-61. PubMed ID: 10749663
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E, Kobayashi K, Tzung KW, Li L, Fuke Y, Chan L.
    Hum Gene Ther; 1997 Nov 01; 8(16):1921-33. PubMed ID: 9382958
    [Abstract] [Full Text] [Related]

  • 17. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
    Takahashi S.
    J Atheroscler Thromb; 2017 Jun 01; 24(6):552-559. PubMed ID: 28428482
    [Abstract] [Full Text] [Related]

  • 18. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
    Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gåfvels M, Kozarsky KF, Chappell DA, Strauss JF, Strickland DK.
    J Biol Chem; 1995 Nov 03; 270(44):26550-7. PubMed ID: 7592875
    [Abstract] [Full Text] [Related]

  • 19. Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase.
    Excoffon KJ, Liu G, Miao L, Wilson JE, McManus BM, Semenkovich CF, Coleman T, Benoit P, Duverger N, Branellec D, Denefle P, Hayden MR, Lewis ME.
    Arterioscler Thromb Vasc Biol; 1997 Nov 03; 17(11):2532-9. PubMed ID: 9409224
    [Abstract] [Full Text] [Related]

  • 20. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW.
    J Biol Chem; 2004 Jul 02; 279(27):27941-7. PubMed ID: 15090553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.